yutori, Inc. (TYO:5892)

Inozyme Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025
Period Ending	Aug 7, 2025	Mar 31, 2025
Market Capitalization	24,799	10,206
Enterprise Value	27,889	12,906
Last Close Price	5280.00	2173.00
PE Ratio	84.64	32.50
PS Ratio	2.99	1.23
PB Ratio	11.84	4.87
EV/Sales Ratio	3.36	1.55
EV/EBITDA Ratio	30.99	14.34
EV/EBIT Ratio	41.50	19.21
Debt / Equity Ratio	1.44	1.44
Debt / EBITDA Ratio	3.36	3.36
Quick Ratio	0.58	0.58
Current Ratio	1.55	1.55
Return on Capital Employed (ROCE)	16.60%	16.60%
Earnings Yield	1.27%	3.08%
FCF Yield	-3.29%	-7.99%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.